Reynoso Jamie L. sold $11K of CLOV
Reynoso Jamie L. (CEO, Medicare Advantage) sold 2,360 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) at $4.78 on 2026-06-17 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The CEO’s open-market sale is disclosed with trade date, price, share count, and confirmation of a pre-arranged 10b5-1 plan, limiting interpretive value for future performance.
Market read
Traders may monitor for follow-on insider activity, but this specific disclosure is unlikely to drive a major repricing without accompanying fundamental news.
What to watch
The filing does not disclose any new company-specific catalyst (earnings, guidance, trials, or regulatory actions), so the main tradable element is only short-term sentiment/flow positioning.
Background
The article is a SEC Form 4 insider transaction disclosure for Clover Health Investments Corp. (DE).
Ticker impact
Clover Health CEO Jamie L. Reynoso filed a Form 4 selling 2,360 shares at $4.7800 on 2026-06-17 under a 10b5-1 plan.
Low likelihood of a sustained price move; any impact is likely short-lived and sentiment-driven.
The filing is a disclosed open-market sale by an officer, explicitly under a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.
Market effects
Minimal; this is company-specific insider transaction with no stated operational/regulatory change.
None indicated.
None indicated.
Counterpoint
Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations, so traders may ignore it for fundamentals.
Key entities
- issuerClover Health Investments Corp. (DE)
Subject of the Form 4 insider transaction; CEO sold shares under a 10b5-1 plan.
- insiderReynoso Jamie L.
CEO, Medicare Advantage; reported open-market sale of 2,360 shares.
